Raha Samraat S. 4
4 · MYRIAD GENETICS INC · Filed Jun 2, 2025
Insider Transaction Report
Form 4
Raha Samraat S.
DirectorPresident and CEO
Transactions
- Award
Common Stock
2025-05-31$3.56/sh+1,498$5,336→ 482,738 total
Footnotes (1)
- [F1]These shares were acquired under the Myriad Genetics, Inc. Amended and Restated 2012 Employee Stock Purchase Plan, in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).